AXIN2 and cancer: A recent interrogation of the cBioPortal for Cancer Genomics database (Cerami et al., 2012) highlights APC, AXIN2, and β-catenin mutations in ≈67%, ≈5%, and ≈6% of colorectal carcinomas, respectively (Bugter et al., 2021).